BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Scherübl H, Streller B, Stabenow R, Herbst H, Höpfner M, Schwertner C, Steinberg J, Eick J, Ring W, Tiwari K, Zappe SM. Clinically detected gastroenteropancreatic neuroendocrine tumors are on the rise: Epidemiological changes in Germany. World J Gastroenterol 2013; 19(47): 9012-9019 [PMID: 24379626 DOI: 10.3748/wjg.v19.i47.9012]
URL: https://www.wjgnet.com/1007-9327/full/v19/i47/9012.htm
Number Citing Articles
1
Bestoun Ahmed, Dilendra H. Weerasinghe, Michael S. Nussbaum. Surgery for Cancers of the Gastrointestinal Tract2015; : 157 doi: 10.1007/978-1-4939-1893-5_14
2
Yihebali Chi, Feng Du, Hong Zhao, Jin-Wan Wang, Jian-Qiang Cai. Characteristics and long-term prognosis of patients with rectal neuroendocrine tumorsWorld Journal of Gastroenterology 2014; 20(43): 16252-16257 doi: 10.3748/wjg.v20.i43.16252
3
Rui Wang, Sonmoon Mohapatra, Manol Jovani, Venkata S. Akshintala, Ayesha Kamal, Olaya Gutierrez Brewer, Vivek Kumbhari, Eun Ji Shin, Marcia I. Canto, Mouen A. Khashab, Vikesh K. Singh, Anne Marie Lennon, Anthony Nicholas Kalloo, Saowanee Ngamruengphong. Risk factors for lymph node metastasis and survival of patients with nonampullary duodenal carcinoid tumors treated with endoscopic therapy versus surgical resection: analysis of the Surveillance, Epidemiology, and End Results programGastrointestinal Endoscopy 2021; 93(6): 1384 doi: 10.1016/j.gie.2020.12.012
4
J. Eick, J. Steinberg, C. Schwertner, W. Ring, H. Scherübl. Neuroendokrine Tumoren des Rektums: endoskopische TherapieDer Chirurg 2016; 87(4): 288 doi: 10.1007/s00104-015-0141-6
5
K. Holzer. Gastroenteropankreatische neuroendokrine TumorenDer Chirurg 2014; 85(8): 731 doi: 10.1007/s00104-013-2679-5
6
Detlef Bartsch, Dominik Wiese. Allgemein- und Viszeralchirurgie II2022; : 77 doi: 10.1016/B978-3-437-24812-2.00004-4
7
Sabrina D’Agosto, Elena Fiorini, Francesco Pezzini, Pietro Delfino, Michele Simbolo, Caterina Vicentini, Silvia Andreani, Paola Capelli, Borislav Rusev, Rita T. Lawlor, Claudio Bassi, Luca Landoni, Antonio Pea, Claudio Luchini, Aldo Scarpa, Vincenzo Corbo. Long-term organoid culture of a small intestinal neuroendocrine tumorFrontiers in Endocrinology 2023; 14 doi: 10.3389/fendo.2023.999792
8
Valentina Ambrosini, Davide Campana, Cristina Nanni, Maria Cristina Marzola, Domenico Rubello, Stefano Fanti. 68Ga DOTANOC PET/CT Detects Primary Malignant InsulinomaClinical Nuclear Medicine 2015; 40(2): e132 doi: 10.1097/RLU.0000000000000447
9
Emilio Bertani, Davide Ravizza, Massimo Milione, Sara Massironi, Chiara Maria Grana, Dario Zerini, Alessandra Nella Piccioli, Giuseppe Spinoglio, Nicola Fazio. Neuroendocrine neoplasms of rectum: A management updateCancer Treatment Reviews 2018; 66: 45 doi: 10.1016/j.ctrv.2018.04.003
10
B. C. Kim, Y. E. Kim, H. J. Chang, S. H. Lee, E. G. Youk, D.‐S. Lee, J. B. Lee, E.‐J. Lee, M. J. Kim, D. K. Sohn, J. H. Oh. Lymph node size is not a reliable criterion for predicting nodal metastasis in rectal neuroendocrine tumoursColorectal Disease 2016; 18(7) doi: 10.1111/codi.13377
11
Tiffany J. Sinclair, George A. Poultsides. Islet TumorsAdvances in Surgery 2020; 54: 69 doi: 10.1016/j.yasu.2020.04.004
12
Grigoris Effraimidis, Ulrich Knigge, Maria Rossing, Peter Oturai, Åse Krogh Rasmussen, Ulla Feldt-Rasmussen. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs)Seminars in Cancer Biology 2022; 79: 141 doi: 10.1016/j.semcancer.2021.04.011
13
Christine Koch, Esra Koca, Natalie Filmann, Gabriele Husmann, Jörg Bojunga. Time from first tumor manifestation to diagnosis in patients with GEP-NETMedicine 2021; 100(37): e27276 doi: 10.1097/MD.0000000000027276
14
Adam Daniel Durma, Marek Saracyn, Maciej Kołodziej, Katarzyna Jóźwik-Plebanek, Beata Dmochowska, Waldemar Kapusta, Wawrzyniec Żmudzki, Adrianna Mróz, Beata Kos-Kudła, Grzegorz Kamiński. Epidemiology of Neuroendocrine Neoplasms and Results of Their Treatment with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE—A Six-Year Experience in High-Reference Polish Neuroendocrine Neoplasm CenterCancers 2023; 15(22): 5466 doi: 10.3390/cancers15225466
15
Adam Daniel Durma, Marek Saracyn, Maciej Kołodziej, Katarzyna Jóźwik-Plebanek, Beata Dmochowska, Adrianna Mróz, Wawrzyniec Żmudzki, Grzegorz Kamiński. Radioligand Therapy with [177Lu]Lu-DOTA-TATE or [177Lu]Lu-DOTA-TATE and [90Y]Y-DOTA-TATE in Patients with Neuroendocrine Neoplasms of Unknown Locations, or Locations Other Than the Midgut and Pancreas as Primaries in a G1, G2 and G3 GradePharmaceuticals 2023; 16(9): 1205 doi: 10.3390/ph16091205
16
George C. Nikou, Kalliopi Pazaitou-Panayiotou, Dimitrios Dimitroulopoulos, Georgios Alexandrakis, Pavlos Papakostas, Michalis Vaslamatzis, Philippos Kaldrymidis, Vyron Markussis, Anna Koumarianou. Results of a prospective multicenter neuroendocrine tumor registry reporting on clinicopathologic characteristics of Greek patientsBMC Endocrine Disorders 2016; 16(1) doi: 10.1186/s12902-016-0089-7
17
Mengjie Jiang, Yinuo Tan, Xiaofen Li, Jianfei Fu, Hanguang Hu, Xianyun Ye, Ying Cao, Jinghong Xu, Ying Yuan. Clinicopathological Features and Prognostic Factors of Colorectal Neuroendocrine NeoplasmsGastroenterology Research and Practice 2017; 2017: 1 doi: 10.1155/2017/4206172
18
Marco Gallo, Pasqualino Malandrino, Giuseppe Fanciulli, Francesca Rota, Antongiulio Faggiano, Annamaria Colao. Everolimus as first line therapy for pancreatic neuroendocrine tumours: current knowledge and future perspectivesJournal of Cancer Research and Clinical Oncology 2017; 143(7): 1209 doi: 10.1007/s00432-017-2407-5
19
Zijian Wu, Zhijie Wang, Zhaoxu Zheng, Jianjun Bi, Xishan Wang, Qiang Feng. <p>Risk Factors for Lymph Node Metastasis and Survival Outcomes in Colorectal Neuroendocrine Tumors</p>Cancer Management and Research 2020; : 7151 doi: 10.2147/CMAR.S256723
20
Shunda Du, Zi Wang, Xinting Sang, Xin Lu, Yongchang Zheng, Haifeng Xu, Yiyao Xu, Tianyi Chi, Haitao Zhao, Wenze Wang, Quancai Cui, Shouxian Zhong, Jiefu Huang, Yilei Mao. Surgical Resection Improves the Outcome of the Patients With Neuroendocrine Tumor Liver MetastasesMedicine 2015; 94(2): e388 doi: 10.1097/MD.0000000000000388
21
Andrea Mafficini, Aldo Scarpa. Genetics and Epigenetics of Gastroenteropancreatic Neuroendocrine NeoplasmsEndocrine Reviews 2019; 40(2): 506 doi: 10.1210/er.2018-00160
22
ZHIQIANG WANG, WENLIANG LI, TIANXING CHEN, JUN YANG, LILIN LUO, LIANYU ZHANG, BAOCUN SUN, RUI LIANG. Retrospective analysis of the clinicopathological characteristics of gastrointestinal neuroendocrine neoplasmsExperimental and Therapeutic Medicine 2015; 10(3): 1084 doi: 10.3892/etm.2015.2634
23
Aaron I. Vinik, Edward M. Wolin, Nilani Liyanage, Edda Gomez-Panzani, George A. Fisher. Evaluation of Lanreotide Depot/Autogel Efficacy and Safety as a Carcinoid Syndrome Treatment (Elect): A Randomized, Double-Blind, Placebo-Controlled TrialEndocrine Practice 2016; 22(9): 1068 doi: 10.4158/EP151172.OR
24
Emanuele Leoncini, Paolo Boffetta, Michail Shafir, Katina Aleksovska, Stefania Boccia, Guido Rindi. Increased incidence trend of low-grade and high-grade neuroendocrine neoplasmsEndocrine 2017; 58(2): 368 doi: 10.1007/s12020-017-1273-x
25
Wojciech Błogowski, Anna Madej-Michniewicz, Natalia Marczuk, Barbara Dołęgowska, Teresa Starzyńska. Interleukins 17 and 23 in patients with gastric neoplasmsScientific Reports 2016; 6(1) doi: 10.1038/srep37451
26
Arthur I Kooyker, Wieke HM Verbeek, José G van den Berg, Margot ET Tesselaar, Monique E van Leerdam. Change in incidence, characteristics and management of colorectal neuroendocrine tumours in the Netherlands in the last decadeUnited European Gastroenterology Journal 2020; 8(1): 59 doi: 10.1177/2050640619865113
27
Nupur K. Purohit, Rashmi G. Shah, Samuel Adant, Michael Hoepfner, Girish M. Shah, Jean-Mathieu Beauregard. Potentiation of 177Lu-octreotate peptide receptor radionuclide therapy of human neuroendocrine tumor cells by PARP inhibitorOncotarget 2018; 9(37): 24693 doi: 10.18632/oncotarget.25266
28
E. Leoncini, G. Carioli, C. La Vecchia, S. Boccia, G. Rindi. Risk factors for neuroendocrine neoplasms: a systematic review and meta-analysisAnnals of Oncology 2016; 27(1): 68 doi: 10.1093/annonc/mdv505
29
Fausto Sessa, Roberta Maragliano. Pancreatic Neuroendocrine Neoplasms2015; : 1 doi: 10.1007/978-3-319-17235-4_1
30
Qin Zhang, Cheng-Jun Lu, Xiang Zhang, Zhe Ma, Qi Xin, Chuan-Shan Zhang. Neuroendocrine Neoplasms of the Major Duodenal Papilla With Focus on Histopathological Features and PrognosisInternational Journal of Surgical Pathology 2015; 23(6): 433 doi: 10.1177/1066896915586808
31
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie2017; : 1 doi: 10.1007/978-3-662-49083-9_30-1
32
Fara Uccelli, F. Gavazzi, G. Capretti, M. Virdis, M. Montorsi, A. Zerbi. Parenchyma-sparing surgery for pancreatic endocrine tumorsUpdates in Surgery 2016; 68(3): 313 doi: 10.1007/s13304-016-0400-1
33
Ashwini Kalshetty, Anant Ramaswamy, Vikas Ostwal, Sandip Basu. Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumorsNuclear Medicine Communications 2018; 39(12): 1143 doi: 10.1097/MNM.0000000000000926
34
Frank Weber, Andreas Machens, Henning Dralle. The Pancreas2023; : 857 doi: 10.1002/9781119876007.ch111
35
Frank Weber, Andreas Machens, Henning Dralle. The Pancreas2023; : 833 doi: 10.1002/9781119876007.ch108
36
Henning Dralle, Phuong Nguyen Thanh, Andreas Machens. The Pancreas2018; : 982 doi: 10.1002/9781119188421.ch130
37
Detlef K. Bartsch, Elisabeth Maurer, Katharina Holzer. Endokrine ChirurgieSpringer Reference Medizin 2023; : 521 doi: 10.1007/978-3-662-63317-5_46
38
B. Niederle, U.-F. Pape, F. Costa, D. Gross, F. Kelestimur, U. Knigge, K. Öberg, M. Pavel, A. Perren, C. Toumpanakis, J. O''Connor, D. O''Toole, E. Krenning, N. Reed, R. Kianmanesh. ENETS Consensus Guidelines Update for Neuroendocrine Neoplasms of the Jejunum and IleumNeuroendocrinology 2016; 103(2): 125 doi: 10.1159/000443170
39
Lior H. Katz, Zohar Levi, Gilad Twig, Jeremy D. Kark, Adi Leiba, Estela Derazne, Irena Liphshiz, Lital Keinan‐Boker, Sapir Eisenstein, Arnon Afek. Risk factors associated with gastroenteropancreatic neuroendocrine tumors in a cohort of 2.3 million Israeli adolescentsInternational Journal of Cancer 2018; 143(8): 1876 doi: 10.1002/ijc.31589
40
Nina Grundmann, Sven Voigtländer, Amir Hakimhashemi, Ulrich‐Frank Pape, Martin Meyer, Jacqueline Müller‐Nordhorn. Site‐specific trends in gastroenteropancreatic neuroendocrine neoplasms in Bavaria, GermanyCancer Medicine 2023; 12(19): 19949 doi: 10.1002/cam4.6510
41
H. Scherübl, F. Raue, K. Frank-Raue. Neuroendokrine TumorenDer Radiologe 2019; 59(11): 952 doi: 10.1007/s00117-019-0574-x
42
Martina T. Mogl, Robert Öllinger, Henning Jann, Bernhard Gebauer, Uli Fehrenbach, Holger Amthauer, Christoph Wetz, Moritz Schmelzle, Nathanael Raschzok, Felix Krenzien, Peter E. Goretzki, Johann Pratschke, Wenzel Schoening. Differenzierte Therapiestrategie bei Lebermetastasen gastro-entero-pankreatischer Neuroendokriner NeoplasienZentralblatt für Chirurgie - Zeitschrift für Allgemeine, Viszeral-, Thorax- und Gefäßchirurgie 2022; 147(03): 270 doi: 10.1055/a-1830-8442
43
Henning Dralle, Phuong Nguyen Thanh, Andreas Machens. The Pancreas2018; : 994 doi: 10.1002/9781119188421.ch132
44
Benjamin E. White, Brian Rous, Kandiah Chandrakumaran, Kwok Wong, Catherine Bouvier, Mieke Van Hemelrijck, Gincy George, Beth Russell, Rajaventhan Srirajaskanthan, John K. Ramage. Incidence and survival of neuroendocrine neoplasia in England 1995–2018: A retrospective, population-based studyThe Lancet Regional Health - Europe 2022; 23: 100510 doi: 10.1016/j.lanepe.2022.100510
45
Hossein Yahyazadeh, Marzieh Beheshti, Sahel Valadan Tahbaz. Gastrointestinal Neuroendocrine Tumours: A Single-Centre ExperienceForum of Clinical Oncology 2022; 13(1): 3 doi: 10.2478/fco-2022-0004
46
Toshihiko Masui, Tetsuhide Ito, Izumi Komoto, Shinji Uemoto. Recent epidemiology of patients with gastro-entero-pancreatic neuroendocrine neoplasms (GEP-NEN) in Japan: a population-based studyBMC Cancer 2020; 20(1) doi: 10.1186/s12885-020-07581-y
47
Cheng Fang, Wei Wang, Yu Zhang, Xingyu Feng, Jian Sun, Yujie Zeng, Ye Chen, Yong Li, Minhu Chen, Zhiwei Zhou, Jie Chen. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South ChinaChinese Journal of Cancer 2017; 36(1) doi: 10.1186/s40880-017-0218-3
48
Barbara Altieri, Luigi Barrea, Roberta Modica, Giovanna Muscogiuri, Silvia Savastano, Annamaria Colao, Antongiulio Faggiano. Nutrition and neuroendocrine tumors: An update of the literatureReviews in Endocrine and Metabolic Disorders 2018; 19(2): 159 doi: 10.1007/s11154-018-9466-z
49
Heba Alwan, Stefano La Rosa, Peter Andreas Kopp, Simon Germann, Manuela Maspoli‐Conconi, Christine Sempoux, Jean‐Luc Bulliard. Incidence trends of lung and gastroenteropancreatic neuroendocrine neoplasms in SwitzerlandCancer Medicine 2020; 9(24): 9454 doi: 10.1002/cam4.3524
50
Anna Lorenz, Sebastian Lenkiewicz, Mateusz Kozłowski, Sebastian Kwiatkowski, Aneta Cymbaluk-Płoska. Neuroendocrine Neoplasms of the Gastrointestinal Tract versus Neuroendocrine Neoplasms of the Gynaecological Tract—Comparison of the Risk Factors and Non-Surgical Treatment EfficacyInternational Journal of Molecular Sciences 2023; 24(7): 6853 doi: 10.3390/ijms24076853
51
Markus Brand, Stanislaus Reimer, Joachim Reibetanz, Sven Flemming, Marko Kornmann, Alexander Meining. Endoscopic full thickness resection vs. transanal endoscopic microsurgery for local treatment of rectal neuroendocrine tumors - a retrospective analysisInternational Journal of Colorectal Disease 2021; 36(5): 971 doi: 10.1007/s00384-020-03800-x
52
Raziye Boyar Cetinkaya, Bjarte Aagnes, Espen Thiis-Evensen, Steinar Tretli, Deidi S. Bergestuen, Svein Hansen. Trends in Incidence of Neuroendocrine Neoplasms in Norway: A Report of 16,075 Cases from 1993 through 2010Neuroendocrinology 2017; 104(1): 1 doi: 10.1159/000442207
53
Monika Szeliga, Jarosław Ćwikła, Marta Obara-Michlewska, Andrzej Cichocki, Jan Albrecht. Glutaminases in slowly proliferating gastroenteropancreatic neuroendocrine neoplasms/tumors (GEP-NETs): Selective overexpression of mRNA coding for the KGA isoformExperimental and Molecular Pathology 2016; 100(1): 74 doi: 10.1016/j.yexmp.2015.11.017
54
Federica Cavalcoli, Aoife Garrahy, Marco Castellaneta, Gianluca Tamagno. Neuroendocrine Tumors in Real Life2018; : 3 doi: 10.1007/978-3-319-59024-0_1
55
Peter E. Goretzki, Martina T. Mogl, Aycan Akca, Johann Pratschke. Curative and palliative surgery in patients with neuroendocrine tumors of the gastro-entero-pancreatic (GEP) tractReviews in Endocrine and Metabolic Disorders 2018; 19(2): 169 doi: 10.1007/s11154-018-9469-9
56
Aldo Scarpa. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumoursAnnales d'Endocrinologie 2019; 80(3): 153 doi: 10.1016/j.ando.2019.04.010
57
Matteo Regolo, Nicolas Cardaci, Clara Salmeri, Alfredo Laudani, Michele Colaci, Massimo Ippolito, Fabio Motta, Salvatore Magrì, Stefanie Parisi, Alfredo Gaetano Torcitto, Lorenzo Malatino. Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature ReviewJournal of Clinical Medicine 2023; 12(20): 6617 doi: 10.3390/jcm12206617
58
Francesca Valent, Annarita Tullio, Elda Kara, Claudia Cipri, Silvia M. Sciannimanico, Fabio Vescini, Franco Grimaldi. A Retrospective Cohort Study of Histology-Proven Neuroendocrine Neoplasms in the Italian Area of UdineEndocrine, Metabolic & Immune Disorders - Drug Targets 2021; 21(3): 448 doi: 10.2174/1871530320666200713093533
59
Wojciech Błogowski, Ewa Zuba-Surma, Daria Sałata, Marta Budkowska, Barbara Dołęgowska, Teresa Starzyńska. Peripheral trafficking of bone-marrow-derived stem cells in patients with different types of gastric neoplasmsOncoImmunology 2016; 5(4): e1099798 doi: 10.1080/2162402X.2015.1099798
60
Elizabeth Kessel, Monica Naparst, Naomi Alpert, Kelly Diaz, Eugene Ahn, Edward Wolin, Emanuela Taioli, Michelle Kang Kim. Racial Differences in Gastroenteropancreatic Neuroendocrine Tumor Treatment and Survival in the United StatesPancreas 2021; 50(1): 29 doi: 10.1097/MPA.0000000000001707
61
Andrea Mafficini, Aldo Scarpa. Genomic landscape of pancreatic neuroendocrine tumours: the International Cancer Genome ConsortiumJournal of Endocrinology 2018; 236(3): R161 doi: 10.1530/JOE-17-0560
62
Niklas Gebauer, Maria Ziehm, Judith Gebauer, Armin Riecke, Sebastian Meyhöfer, Birte Kulemann, Nikolas von Bubnoff, Konrad Steinestel, Arthur Bauer, Hanno M. Witte. The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro–Entero–Pancreatic (GEP-NEN) SystemCancers 2022; 14(21): 5465 doi: 10.3390/cancers14215465
63
Riccardo Ariotti, Stefano Partelli, Francesca Muffatti, Valentina Andreasi, Francesca Della Sala, Massimo Falconi. How should incidental NEN of the pancreas and gastrointestinal tract be followed?Reviews in Endocrine and Metabolic Disorders 2018; 19(2): 139 doi: 10.1007/s11154-018-9445-4
64
Michael Rassner, Harald Lahner, Nikolas von Bubnoff, Frank Lammert. Geriatrische Onkologie2018; : 381 doi: 10.1007/978-3-662-48727-3_30
65
Kira Oleinikov, Alain Dancour, Julia Epshtein, Ariel Benson, Haggi Mazeh, Ilanit Tal, Shay Matalon, Carlos A Benbassat, Dan M Livovsky, Eran Goldin, David J Gross, Harold Jacob, Simona Grozinsky-Glasberg. Endoscopic Ultrasound-Guided Radiofrequency Ablation: A New Therapeutic Approach for Pancreatic Neuroendocrine TumorsThe Journal of Clinical Endocrinology & Metabolism 2019; 104(7): 2637 doi: 10.1210/jc.2019-00282
66
Katsunori Matsueda, Takashi Kanesaka, Masanori Kitamura, Satoki Shichijo, Akira Maekawa, Sachiko Yamamoto, Yoji Takeuchi, Koji Higashino, Noriya Uedo, Tomoki Michida, Keiichiro Honma, Isao Miyashiro, Ryu Ishihara. Favorable long‐term outcomes of endoscopic resection for nonampullary duodenal neuroendocrine tumorJournal of Gastroenterology and Hepatology 2021; 36(12): 3329 doi: 10.1111/jgh.15586
67
M. Falconi, B. Eriksson, G. Kaltsas, D.K. Bartsch, J. Capdevila, M. Caplin, B. Kos-Kudla, D. Kwekkeboom, G. Rindi, G. Klöppel, N. Reed, R. Kianmanesh, R.T. Jensen. ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine TumorsNeuroendocrinology 2016; 103(2): 153 doi: 10.1159/000443171
68
Harun Ilhan, Moritz Ludwig Schnitzer, Johannes Rübenthaler. Neuroendokrine Tumoren – von der morphologischen zur funktionellen BildgebungDer Nuklearmediziner 2021; 44(04): 313 doi: 10.1055/a-1652-4899
69
Detlef K. Bartsch, Elisabeth Maurer, Katharina Holzer. Viszeral- und AllgemeinchirurgieSpringer Reference Medizin 2022; : 1 doi: 10.1007/978-3-662-61724-3_46-1
70
Satya Das, Arvind Dasari. Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?Current Oncology Reports 2021; 23(4) doi: 10.1007/s11912-021-01029-7
71
K. Passek, N. Zulauf, M. H. Bendels, M. Braun, G. M. Oremek. Der Tumormarker SerotoninZentralblatt für Arbeitsmedizin, Arbeitsschutz und Ergonomie 2019; 69(5): 306 doi: 10.1007/s40664-018-0319-0
72
Giovanna Muscogiuri, Barbara Altieri, Manuela Albertelli, Andrea Dotto, Roberta Modica, Luigi Barrea, Giuseppe Fanciulli, Tiziana Feola, Roberto Baldelli, Rosaria Maddalena Ruggeri, Marco Gallo, Valentina Guarnotta, Pasqualino Malandrino, Erika Messina, Mary Anna Venneri, Elisa Giannetta, Diego Ferone, Annamaria Colao, Antongiulio Faggiano. Epidemiology of pancreatic neuroendocrine neoplasms: a gender perspectiveEndocrine 2020; 69(2): 441 doi: 10.1007/s12020-020-02331-3
73
Harun Ilhan, Moritz Ludwig Schnitzer, Johannes Rübenthaler. Neuroendokrine Tumoren – von der morphologischen zur funktionellen BildgebungRadiopraxis 2022; 15(02): E35 doi: 10.1055/a-1714-2040
74
Dominik Reher, Uli Fehrenbach, Antonin Kayser, Ulrich-Frank Pape, Frank Oliver Henes, Birgit Cremer, Dieter Hörsch, Jakob Izbicki, Ansgar Wilhelm Lohse, Anja Rinke, Jörg Schrader. Localization Defines Streptozotocin/5-FU Response in Primary Pancreatic Neuroendocrine TumoursNeuroendocrinology 2022; 112(6): 595 doi: 10.1159/000518895
75
Luca Giraldi, Alessia Vecchioni, Greta Carioli, Mirna Bilotta, Stefano La Rosa, Andrea Imperatori, Marco Volante, Maria Pia Brizzi, Frediano Inzani, Gianluigi Petrone, Giovanni Schinzari, Antonio Bianchi, Stefano Margaritora, Sergio Alfieri, Carlo La Vecchia, Stefania Boccia, Guido Rindi. Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control studyEndocrine 2021; 71(1): 233 doi: 10.1007/s12020-020-02464-5
76
Valentina Ambrosini, Stefano Fanti. Diagnostic and Therapeutic Nuclear Medicine for Neuroendocrine Tumors2017; : 351 doi: 10.1007/978-3-319-46038-3_16
77
Aman Chauhan, Qian Yu, Neha Ray, Zainab Farooqui, Bin Huang, Eric B. Durbin, Thomas Tucker, Mark Evers, Susanne Arnold, Lowell B. Anthony. Global burden of neuroendocrine tumors and changing incidence in KentuckyOncotarget 2018; 9(27): 19245 doi: 10.18632/oncotarget.24983
78
Jack Cope, Raj Srirajaskanthan. Rectal Neuroendocrine Neoplasms: Why Is There a Global Variation?Current Oncology Reports 2022; 24(3): 257 doi: 10.1007/s11912-021-01172-1
79
H. Azam-Zangeneh, M. Müller-Schilling, A. Kandulski. Neuroendokrine Neoplasien des MagensDer Gastroenterologe 2018; 13(2): 126 doi: 10.1007/s11377-018-0231-3
80
Frediano Inzani, Gianluigi Petrone, Guido Rindi. Pancreatic Neuroendocrine Neoplasms2015; : 51 doi: 10.1007/978-3-319-17235-4_6
81
Concetta Sciammarella, Amalia Luce, Ferdinando Riccardi, Carmela Mocerino, Roberta Modica, Massimiliano Berretta, Gabriella Misso, Alessia Maria Cossu, Annamaria Colao, Giovanni Vitale, Alois Necas, Jan Fedacko, Marilena Galdiero, Pierpaolo Correale, Antongiulio Faggiano, Michele Caraglia, Anna Capasso, Anna Grimaldi. Lanreotide Induces Cytokine Modulation in Intestinal Neuroendocrine Tumors and Overcomes Resistance to EverolimusFrontiers in Oncology 2020; 10 doi: 10.3389/fonc.2020.01047
82
Surabhi Pathak, Jason S. Starr, Thorvardur Halfdanarson, Mohamad Bassam Sonbol. Understanding the increasing incidence of neuroendocrine tumorsExpert Review of Endocrinology & Metabolism 2023; 18(5): 377 doi: 10.1080/17446651.2023.2237593
83
Saadettin Kilickap, Kadir Mutlu Hayran. Neuroendocrine Tumours2015; : 23 doi: 10.1007/978-3-662-45215-8_3
84
Miral Sadaria Grandhi, Kelly J. Lafaro, Timothy M. Pawlik. Role of Locoregional and Systemic Approaches for the Treatment of Patients with Metastatic Neuroendocrine TumorsJournal of Gastrointestinal Surgery 2015; 19(12): 2273 doi: 10.1007/s11605-015-2931-z
85
Lisa Reinhard, Martina T. Mogl, Fabian Benz, Agata Dukaczewska, Frederike Butz, Eva Maria Dobrindt, Frank Tacke, Johann Pratschke, Peter E. Goretzki, Henning Jann. Prognostic differences in grading and metastatic lymph node pattern in patients with small bowel neuroendocrine tumorsLangenbeck's Archives of Surgery 2023; 408(1) doi: 10.1007/s00423-023-02956-8
86
Harun Ilhan, Moritz Schnitzer, Johannes Rübenthaler. Neuroendokrine Tumoren – von der morphologischen zur funktionellen BildgebungOnkologie up2date 2022; 4(01): 93 doi: 10.1055/a-1712-0674
87
Anna Madej-Michniewicz, Marta Budkowska, Daria Sałata, Barbara Dołęgowska, Teresa Starzyńska, Wojciech Błogowski. Evaluation of selected interleukins in patients with different gastric neoplasms: a preliminary reportScientific Reports 2015; 5(1) doi: 10.1038/srep14382
88
Ioannis Mintziras, Tobias Keck, Jens Werner, Stefan Fichtner‐Feigl, Uwe Wittel, Norbert Senninger, Thorsten Vowinkel, Jörg Köninger, Matthias Anthuber, Bernd Geißler, Detlef Klaus Bartsch, Michael Ghadimi, Stefan Post, Torsten J. Wilhelm, Christoph‐Thomas Germer, Waldemar Uhl, Orlin Belyaev, Thomas Kraus, Helmut Witzigmann, Merten Hommann, Ernst Klar, Matthias Glanemann, Carsten Gutt, Thomas Manger, Hans‐Jörg Krämling, Jörg C. Kalff, Tim R. Glowka, Natascha C. Nüssler, Jörg‐Peter Ritz, Winfried Padberg, Anton J. Kroesen, Albrecht Stier, Dietmar Lorenz, Wolf Otto Bechstein, Karl‐Jürgen Oldhafer, Sven Eisold, Ute Tröbs, Hans‐Bernd Reith, Franz‐Josef Schumacher, Elke Wagler, Stefan Farkas, Frank Klammer, Matthias Schwarzbach, Marco Niedergethmann, Norbert Runkel, Pompiliu Piso, Eric P. M. Lorenz, Christian Mönch, Steffanie Bieck, Robert Grützmann, Max Brunner, Helmut Friess. Implementation of Current ENETS Guidelines for Surgery of Small (≤2 cm) Pancreatic Neuroendocrine Neoplasms in the German Surgical Community: An Analysis of the Prospective DGAV StuDoQ|Pancreas RegistryWorld Journal of Surgery 2019; 43(1): 175 doi: 10.1007/s00268-018-4751-2
89
Margarita Ptasnuka, Arturs Ozolins, Zenons Narbuts, Arturs Truskovs, Maris Sperga, Haralds Plaudis. Epidemiological Data and Treatment of Gastroenteropancreatic Neuroendocrine Neoplasms: Insights From Tertiary Referral Hospitals in LatviaWorld Journal of Surgery 2020; 44(2): 585 doi: 10.1007/s00268-019-05219-0
90
Daisuke Takayanagi, Hourin Cho, Erika Machida, Atsushi Kawamura, Atsuo Takashima, Satoshi Wada, Takuya Tsunoda, Takashi Kohno, Kouya Shiraishi. Update on Epidemiology, Diagnosis, and Biomarkers in Gastroenteropancreatic Neuroendocrine NeoplasmsCancers 2022; 14(5): 1119 doi: 10.3390/cancers14051119
91
Min-Sun Kwak, Su Jin Chung, Jong In Yang, Jong Pil Im, Min Jung Park, Cheol Lee, Joo Sung Kim. Long-term Outcome of Small, Incidentally Detected Rectal Neuroendocrine Tumors Removed by Simple Excisional Biopsy Compared With the Advanced Endoscopic Resection During Screening ColonoscopyDiseases of the Colon & Rectum 2018; 61(3): 338 doi: 10.1097/DCR.0000000000000905
92
Giovanna Muscogiuri, Luigi Barrea, Tiziana Feola, Marco Gallo, Erika Messina, Mary Anna Venneri, Antongiulio Faggiano, Annamaria Colao. Pancreatic Neuroendocrine Neoplasms: Does Sex Matter?Trends in Endocrinology & Metabolism 2020; 31(9): 631 doi: 10.1016/j.tem.2020.02.010
93
Timothy L. Fitzgerald, Samuel O. Dennis, Swapnil D. Kachare, Nasreen A. Vohra, Emmanuel E. Zervos. Increasing incidence of duodenal neuroendocrine tumors: Incidental discovery of indolent disease?Surgery 2015; 158(2): 466 doi: 10.1016/j.surg.2015.03.042
94
Sylvia L. Asa, David S. Klimstra. The Spectrum of Neuroendocrine Neoplasia2021; : 245 doi: 10.1007/978-3-030-54391-4_11
95
Yibo Cai, Zhuo Liu, Lai Jiang, Dening Ma, Zhenyuan Zhou, Haixing Ju, Yuping Zhu. Patterns of Lymph Node Metastasis and Optimal Surgical Strategy in Small (≤20 mm) Gastroenteropancreatic Neuroendocrine TumorsFrontiers in Endocrinology 2022; 13 doi: 10.3389/fendo.2022.871830